SEA 1934 Rule 13a-14
-
SEC charges Kiromic BioPharma for failing to disclose FDA holds
Two former executives were fined, but the company itself will not receive a civil penalty due to its self-reporting.
Two former executives were fined, but the company itself will not receive a civil penalty due to its self-reporting.